SEASONAL VACCINATIONS

FLU SHOT, COVID-19 & RSV UPDATES

Vaccination Updates

This page will be updated regularly to display current inventory during respiratory season

  • BOOK HERE

    Regular flu shots 6months – 64 years OUT OF STOCK

    Regular 65+ flu shots OUT OF STOCK

    High dose 65+ flu shots OUT OF STOCK

  • For KMC patients and general public (12+ years of age) to book.

    BOOK HERE

    OUT OF STOCK until next covid booster becomes available spring or Fall 2026

    Covid Vaccine: PFIZER

  • ***RSV is publicly funded to all individuals aged 75 and older***

    75+ AREXVY® Vaccine: Available now, LOW STOCK
    BOOK HERE

    HIGH RISK 60-74, AREXVY® Vaccine: LOW STOCK
    BOOK HERE
    Eligibility Criteria:

    • lives in long term care/retirement residences

    • on hemo/ or peritoneal dialysis

    • patient with glomerulonephritis (GN) and is moderately-severely immunocompromised

    • organ/stem cell transplant recipients

    • patients experiencing homelessness

    • identify as First Nations, Inuit, or Metis

  • Beyfortus (weight 5kg+) IN STOCK
    BOOK HERE

    Beyfortus (weight under 5kg) Limited doses LOW STOCK
    BOOK HERE

    Beyfortus® is publicly funded for administration in infants in the following groups:

    • Infants born before the RSV season (born on or after April 1, 2025 and younger than 8 months of age at time of administration).

    • Infants born during the season who did NOT receive Beyfortus in hospital.

    • Infants born outside of hospital settings.

    Children up to 24 months of age who remain vulnerable from severe RSV disease through their second RSV season, following discussion with a health care provider, including:

    • chronic lung disease of prematurity (CLD), including bronchopulmonary dysplasia/chronic lung disease

    • hemodynamically significant congenital heart disease (CHD)

    • severe immunodeficiency

    • Down syndrome/Trisomy 21

    • cystic fibrosis with respiratory involvement and/or growth delay neuromuscular disease

    • severe congenital airway anomalies impairing the clearing of respiratory secretions

  • OUT OF STOCK

    RSV Vaccine (ABRYSVO®) for PREGNANT patients 32 to 36 weeks gestational age who will deliver during the RSV season. Only one RSV product is recommended for infant protection. NACI recommends BEYFORTUS® as the preferred option over maternal vaccination in pregnancy, except in specific cases (e.g., high-risk infants born to vaccinated mothers).

    BOOK HERE, or get during your next prenatal visit

    RSV season has ended, check back Fall 2026